A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia

13 Apr 20265 min read0 viewsINTERVENTIONAL Trial

GIST

RECRUITING · INTERVENTIONAL · TREATMENT study · Hypoxic-Ischemic Encephalopathy · Phase 2 · Enrollment 70 · Sponsor: ReAlta Life Sciences, Inc.

Clinical Editorial

Summary

ClinicalTrials.gov published a clinical update in Infectious Disease on 13 Apr 2026. The item focuses on A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia. Open the detail page to review the full original feed content.